Smart Pills Market Growth Report - Industry Overview 2028

Smart Pills Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Application (Capsule Endoscopy, Drug Delivery, and Patient Monitoring), Disease Indication (Gastrointestinal Diseases, Neurological Disorders, Cancer, Inherited Disorders, and Other Disease Indications), and End User (Hospitals and Clinics, Research Institutes, and Home Healthcare)

Publication Month : Mar 2022

  • Report Code : TIPHE100001238
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 197
Inquire Before Buy

PRICING

$4550

$2730

[Research Report] The smart pills market size is expected to grow from US$ 4,019.30 million in 2021 to US$ 9,061.29 million in 2028; it is estimated to record a CAGR of 12.3% from 2022 to 2028.

 

Analyst Perspective

The rise in the geriatric population, growing prevalence of lifestyle-related disorders such as obesity, gastric ulcers, and others, and increase in chronic disorders, including cancer, diabetes, and others are some of the factors that support the growth of smart pills market. Furthermore, growing research and development activities and funding for the development of the smart pill is one of the major factors fueling the smart pills market growth. Moreover, the rise in technological advances relating to smart pills, such as micro-cameras, miniaturization, availability of microprocessors, and others, offer lucrative opportunities for market growth in the future. With the rising cases of dementia and Alzheimer, there is an increased chance that patients may miss their doses of medication or may take the wrong administration, which increases the demand and need for smart pills. Hence, the smart pills market will experience growth in the coming years due to its growth need in the healthcare industry.

Market Overview

Smart pills are capsule-sized ingestible medical devices consisting of elements such as sensors, cameras, patches, and trackers that help in better diagnostics, patient monitoring, as well as targeted drug delivery. They are majorly available in the form of vitamin capsule-sized pills and possess a small wearable sensor patch, an application on a mobile device, and a provider portal. These unique devices can be easily swallowed and offer a non-invasive, thorough examination of the gastrointestinal (GI) tract and many other parts of the body. Smart pill technology helps patients and doctors to track their drug regimen compliance, thereby increasing patient adherence. Estimations suggest that this technology could save around US$100-US$300 billion yearly in the US. The primary drivers of the smart pills market are rising demand for minimally invasive surgical procedures and an increase in strategic collaborations & partnerships on smart pills. Also, increasing demand for drug delivery systems contributes to the growth of the smart pills market.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Smart Pills Market: Strategic Insights

smart-pills-market
Market Size Value inUS$ 4,019.30 Million in 2021
Market Size Value byUS$ 9,061.29 million by 2028
Growth rateCAGR of 12.3% from 2022 to 2028
Forecast Period2022-2028
Base Year2021
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Market Driver

Rising Demand for Minimally Invasive Surgical Procedures to Drive Global Smart Pills Market Growth

The geriatric population is highly susceptible to gastrointestinal disorders. A number of smart pills are being evaluated for potential application in therapeutics and diagnosing numerous acute and chronic diseases. Patients with chronic diseases who follow a specified dose of medication at the target site are anticipated to form a considerable customer base for advanced drug delivery products. Certain benefits offered by smart pills include advanced capsule endoscopy, easy remote patient monitoring, and targeted drug delivery. These factors result in the rising adoption of smart pills to treat gastrointestinal diseases or cancer patients. A growing shift in patient preference toward minimally invasive procedures for treatment is projected to drive the smart pills market growth. As per an article published in IEEE Access in February 2021, minimally invasive medicine has become mainstream due to its crucial clinical significance in delivering low-risk postoperative complications, limited blood loss, reduced postoperative recovery time, and small sizes of associated physiological tissue wounds. These factors result in the rising adoption of smart pills to treat gastrointestinal diseases or cancer patients.

The increasing demand for minimally invasive surgical procedures has led to innovative techniques, such as capsule endoscopy. Capsule endoscopy plays a crucial role in the early diagnosis and proper treatment of these disorders, along with hybrid imaging technologies and new component innovations, and is expected to replace traditional endoscopy methods due to its advantages, including ease of administration and detailed observation of the gastrointestinal tract. For instance, as per the University of Texas Health Science Center, deploying various colorectal cancer screening procedures, such as capsule endoscopy, improves adherence to screening. The university conducted a study comprising haphazardly assigned patients aged 50 to 75 and understood that capsule endoscopy gives better diagnostic results than CT colonography. Therefore, such factors are likely to boost the demand for smart pills, which in turn, drive the smart pills market growth in the forecast period.

Segmental Analysis

Based on disease indication, the smart pills market is categorized into gastrointestinal diseases, neurological disorders, cancer, inherited disorders, and other disease indications. In 2021, the gastrointestinal diseases segment held the largest market share. However, the cancer segment is estimated to register the highest CAGR during the forecast period. The Centers for Disease Control and Prevention (CDC) estimates that 60 to 70 million Americans are affected by gastrointestinal disorders each year, and tens of millions of endoscopic operations are performed as a result of it. Colonoscopies are also performed in millions of cases to diagnose or test for colorectal malignancies. Patients are uncomfortable with traditional, hard scopes used for these procedures, which might cause internal bruising or infection if they are reused on various patients. Thanks to smart pills, invasive procedures are no longer necessary: wireless connection allows real-time data to be transmitted, and developments in battery technology and onboard memory make them viable for long-term sensing from within the body.

Smart pills have transformed the diagnosis of gastrointestinal illness, and they may soon be able to replace traditional diagnostic methods like endoscopy. During a traditional procedure, an endoscopy probe is placed into a patient's esophagus, followed by the upper and lower gastrointestinal tract, for diagnostic purposes. The esophagus lining is in danger of perforation or tears, and the patient will experience discomfort during and after the treatment. However, a smart pill or wireless capsule endoscopy (WCE) can be eaten and manipulated to acquire images with minimum patient preparation, such as sedation. The built-in sensors allow the physician to measure all fluids and gases in the gut, providing a multidimensional image of the human body to the physician. Therefore, above mentioned factors support the growth of the segment in the smart pills market.

Regional Analysis

The Asia Pacific smart pills market was valued at US$ 488.75 million in 2021 and is projected to reach US$ 1,156.22 million by 2028; it is expected to grow at a CAGR of 13.1% during the forecast period. The Asia Pacific smart pills market is segmented into China, Japan, India, Australia, South Korea, and the Rest of APAC. Japan held the largest share of the Asia Pacific smart pills market in 2021. The growth of the smart pills market in the country is primarily driven by massive developments and financial aid that accelerate the adoption and acceptance of smart pills in the country. The growing prevalence of neurological diseases is likely to demand smart pill technology. For instance, in 2018, according to the health ministry, around 4.6 million people suffered from some form of dementia, and the total number is expected to soar to about 7.3 million people, i.e., one in five Japanese aged 65 or above by 2025. Also, the growing prevalence of gastrointestinal diseases in Japan fuel the demand for smart pills. As per the study ‘Trends in Gastrointestinal Diseases in Japan,’ the incidence of gastric cancer is high in East Asian countries, including Japan. It also reported that the incidence of gastroesophageal reflux disease (GERD) and IBD are continuously increasing.

Scientists and researchers have also helped the biotechnology and life science market to grow. Japan Society for the Promotion of Science (JSPS) estimated that nearly US$270 million (30 billion yen) of funds would be available to offer research grants which will further increase the development of new technologies by the researchers. Thus, the establishment of the plants and favorable funds & grants will support the smart pills market growth during the forecast period.

Key Player Analysis

The smart pills market analysis consists of players, such as CapsoVision, Inc.; Medtronic; Check-Cap; PENTAX Medical; Olympus Corporation; BodyCap; Otsuka America Pharmaceutical, Inc.; IntroMedic Co., Ltd; Jinshan Science & Technology.; and RF Co., Ltd. Among the players in the smart pills market, Medtronic and CapsoVision, Inc are the top two players owing to the diversified product portfolio offered.

Recent Developments

Inorganic and organic strategies such as mergers and acquisitions are highly adopted by companies in the smart pills market. A few recent key market developments are listed below: 

  • In January 2022, Novo Nordisk India has launched an oral formulation for an anti-diabetes drug available only as injections. The company claimed the new drug help better control blood sugar levels and weight in adults with type-2 diabetes. For this breakthrough, the company received the Prix Galien Award in 2020, a prestigious award in the industry. The drug was approved in 2020, by the Drugs Controller General of India.
  • In December 2020, CapsoVision, Inc. achieved the International Standard Organization (ISO) 27001 security certification. The scope of the certification includes CapsoVision's headquarters and the company's CapsoCloud software.
  • In August 2020, Otsuka America Pharmaceutical, Inc. announced that it had purchased the assets of Proteus Digital Health, Inc. (Proteus), including assets and intellectual property for its ingestible and wearable sensor technology.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Application, Disease Indication, and End User

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

Frequently Asked Questions


Who are the major players in market the smart pills market?

The smart pills market majorly consists of the players such as CapsoVision, Inc.; Medtronic.; Check-Cap; PENTAX Medical; Olympus Corporation; BodyCap.; Otsuka America Pharmaceutical, Inc.; IntroMedic; Jinshan Science & Technology (Group) Co., Ltd.; and RF Co., Ltd.

What is the smart pills market?

Smart pills are capsule-sized ingestible medical devices consisting of elements such as sensors, cameras, patches, and trackers that help in better diagnostics, patient monitoring, as well as targeted drug delivery. They are majorly available in the form of a vitamin capsule sized pill and possess small wearable sensor patch, an application on a mobile device, and a provider portal.

What are the driving factors for the smart pills market across the country?

The factors that are driving and restraining factors that will affect the smart pills market in the coming years. Factors such as the increase in the demand for minimally invasive devices in the US, and the rise in the gastrointestinal disorders in U.S. characterize the growth in North America. In addition, rapid technological advancements in drug delivery are likely to boost the market for smart pills.

Which segment is dominating the smart pills market?

The global smart pills market based on application, is segmented into capsule endoscopy, drug delivery, and patient monitoring. In 2021, capsule endoscopy segment held largest market share. However, drug delivery is estimated to grow at the fastest CAGR of 13.4% during the forecast period.

The List of Companies - Smart Pills Market

  1. CapsoVision, Inc.
  2. Given Imaging, Inc.
  3. Check-Cap
  4. PENTAX Medical
  5. Olympus
  6. BodyCap
  7. Otsuka America Pharmaceutical, Inc.
  8. IntroMedic
  9. Jinshan Science & Technology (Group) Co., Ltd.
  10. RF Co., Ltd.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Smart Pills Market